Front Row Advisors LLC Boston Scientific Corp Transaction History
Front Row Advisors LLC
- $282 Million
- Q2 2024
A detailed history of Front Row Advisors LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Front Row Advisors LLC holds 300 shares of BSX stock, worth $26,420. This represents 0.01% of its overall portfolio holdings.
Number of Shares
300
Previous 300
-0.0%
Holding current value
$26,420
Previous $20,000
15.0%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BSX
# of Institutions
1,459Shares Held
1.2BCall Options Held
8.14MPut Options Held
8.3M-
Vanguard Group Inc Valley Forge, PA130MShares$11.4 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$11.1 Billion0.22% of portfolio
-
State Street Corp Boston, MA61.5MShares$5.41 Billion0.21% of portfolio
-
Primecap Management CO Pasadena, CA38MShares$3.34 Billion2.15% of portfolio
-
Wellington Management Group LLP Boston, MA32.1MShares$2.83 Billion0.45% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $126B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...